Region I IPP Clinic Staff and Provider Assessment Kim Watson, Jennifer Kawatu.

Slides:



Advertisements
Similar presentations
For primary and secondary care settings
Advertisements

Chlamydia Screening Rates among Pregnancy Test Only Visits in Region I, Andee Krasner, MPH Region I IPP Infrastructure.
Wisconsin State Report RVIPP Meeting March 4-5, 2009 Highlight Updates Screening Projects: Prevalence Evaluation Update; Expanded GC Screening in Milwaukee.
WI State Report RVIPP, Indianapolis, IN June 9-10, 2010.
Michigan Adolescent Screening Project- Community Partnerships MDCH.
Assessment of Chlamydia Rescreening Practices Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
CDC Recommendations for HIV Testing of Adults and Adolescents Christina Price, MPH Delta Region AIDS Education and Training Center.
Revision of Region II IPP Screening Criteria May 16, 2007 Region II IPP Advisory Committee Meeting Cicatelli Associates Inc. New York City.
Once Is Not Enough: Re-screening Sexually Transmitted Disease (STD) Clinic Patients in Six Months to Detect New STDs Once Is Not Enough: Re-screening Sexually.
Repeat Chlamydial Infections in Region III Family Planning Clinics: Implications for Screening Programs Pamela G. Nathanson, Family Planning Council, Inc.
CHOLESTEROL AWARENESS PROGRAM INFORMATIVE PROGRAM.
What do you like the best/least about the clinic? Waterloo Region Nurse Practitioner-Led Clinic.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 1998 Division of STD Prevention.
Appropriate CT/GC Screening & Factors to Consider Becky McCoy MSN, RN, CEN STD Nurse Consultant.
STD Knowledge and Practices of New York City Providers Meighan E. Rogers, MPH Bureau of STD Control, NYC DOHMH Region II IPP Meeting, May 31-June 1, 2006.
Caspher User Satisfaction Survey October Caspher (Chlamydia Awareness Screening Programme for Hull and East Riding) User Satisfaction Survey October.
Analysis of Chlamydia Re-testing Rates Massachusetts Family Planning Update.
Universal HIV Testing Closing the Gap Peter A. Leone, MD Associate Professor of Medicine University of North Carolina Medical Director, NC HIV/STD Prevention.
STEP UP: NYC DOHMH STD School Screening Progress Meighan Rogers, MPH IPP Region II Mtg December, 2007.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
RTI International is a trade name of Research Triangle Institute Untreated chlamydial infection among adolescents and young adults in Baltimore,
Re-Screening of CT Positive Clients in Region X IPP, Goldenkranz S., 1 Fine D. 1 1 Center for Health Training 2010 CDC STD Prevention Meeting,
Cancer Care Ontario A Organizational Overview S Orientation Workshop July 16, 2014 Sheila M Densham, BA, TEACH Health Promotion Coordinator.
Northwest Portland Area Indian Health Board
The Cost Savings and Enhancements of a District’s Wellness Program A Case Study from Broward Presented by: Kay Blake, Training Supervisor Tina Severance-Fonte,
FY 2008 – 2009 AGREEMENT ADDENDA 536 and 541 CHANGES.
Results from the ACHA Pap Test and STI Survey for Calendar Year 2008 American College Health Association Sexual Health Education and Clinical Care Coalition.
Results from the ACHA Pap Test and STI Survey for Calendar Year 2009 American College Health Association Sexual Health Education and Clinical Care Coalition.
Region I IPP Infrastructure Updates Advisory Board Meeting November 12, 2009 Boston, MA.
Healthcare Providers and Folic Acid Results of a 2002 survey assessing obstetric-gynecology and family practice physicians’ awareness and practices regarding.
US Virgin Islands IPP: Use of Limited Resources Taetia Phillips-Dorsett, MS Territorial Director, USVI DOH STD/HIV/TB Program Region II IPP Advisory Meeting.
Chlamydial Infections in the U.S. Steven J Shapiro CCID/NCSHHSTP/DSTDP/PTB Region I Infertility Prevention Project Wells Beach, Maine June 2, 2009 Disclaimer:
1 TITLE X FAMILY PLANNING/HIV INTEGRATION PROJECT Opt Out Process Michael Brannon M.S. HIV/STD Prevention Program Manager (713)
GC Outbreak in Philadelphia Greta Anschuetz, MPH Philadelphia Department of Public Health
Region I IPP Infrastructure Updates Advisory Board Meeting June 15, 2010 Boston, MA.
A Randomized Trial of Screening for Intimate Partner Violence in Young Women Leslie Davidson +, Niki Palmetto +, Kathleen Jones+, Vaughn Rickert+, Vicki.
WI State Report RVIPP Meeting Chicago: February 2-3, 2011.
Pilot Study: Re-screening Adolescent and Young Adult Women for Chlamydia Infection Alison Muse NYSDOH Bureau of STD Control Region II IPP meeting November.
IPP Future’s Project Update June 6 and 7, 2011 Region I IPP Advisory Board Meeting.
1 Findings from Recent Consumer and Health-Care Provider Surveys Adelphi Research by Design supported by sanofi pasteur David R. Johnson, MD, MPHNVAC Meeting.
Region II IPP Data & Infrastructure Performance Measures Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
1 DETR- Rehabilitation Division SFY 2006 Satisfaction Survey BY: Pamela Gallion University of Nevada, Las Vegas.
Alcohol Consumption and Diabetes Preventive Practices: Preliminary Findings from the U.S.-Mexico Border Patrice A.C. Vaeth, Dr.P.H. Raul Caetano, M.D.,
IPP Measures of Effectiveness Utilization of Data to Evaluate and Inform Project Activities December 12, 2007 Kelly Morrison Opdyke, MPH Region II Infertility.
Results from the ACHA Pap Test and STI Survey for Calendar Year 2007 American College Health Association Sexual Health Education and Clinical Care Coalition.
Infrastructure Update Jennifer Kawatu Kim Watson Andee Krasner
Targeting Chlamydia Screening Resources Region II IPP Advisory Meeting May 31, 2006 Kelly Opdyke, MPH Cicatelli Associates Inc.
BASELINE ASSESSMENT OF CHLAMYDIA REINFECTION IN REGION VIII FAMILY PLANNING CLINICS FOR Hamby, Y, JSI Research & Training Institute Donovan,
SEXUAL HEALTH: SCREENING, VACCINES AND REFERRALS Dr Kate Morton.
Focus Area 25 Sexually Transmitted Diseases Progress Review July 21, 2004.
Region I IPP Data Presentation Advisory Board Meeting June 2008 Wells, ME.
Expedited Partner Therapy The Denver Experience Cornelis A. Rietmeijer, MD, PhD Denver Public Health Department.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2004 Division of STD Prevention.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
IPP Infrastructure Measures of Effectiveness: Preliminary Data and Next Steps Kelly Morrison Opdyke, MPH Region II Infertility Prevention Project Cicatelli.
Improving Pneumococcal Vaccination Rates David Diamant MD, Molly Benedum MD Center for Family Medicine Aim The aim is to increase awareness of pneumococcal.
J. Mossong1, N. Majéry2, C. Mardaga3 , M. Muller4, F. Schneider1
Universal Screening to Assess Chlamydia Prevalence and Risk Among Older Women Attending Family Planning Clinics in Wisconsin Roberta (Bobbie) McDonald.
Cost of Screening Outside of IPP Chlamydia Screening Guidelines
Martin Goldberg1, Daniel R. Newman2, TA Peterman2,
Overview.
Region I IPP Data Update Advisory Board Meeting
Family Planning & STDP Brainstorming
Region I IPP Data Update Region I IPP Advisory Board Meeting
M Javanbakht, S Guerry, LV Smith, P Kerndt
Region I IPP Data Update Region I IPP Advisory Board Meeting
Region I IPP Data Update Region I IPP Advisory Board Meeting
Region I Sneak Preview Future of IPP Regional Assessment Findings
Gonorrhea Screening: What Do the Data Tell Us?
Presentation transcript:

Region I IPP Clinic Staff and Provider Assessment Kim Watson, Jennifer Kawatu

Provider Assessment The primary goal is to inform the project around improvement of the regional IPP Performance measures – screening coverage and adherence to screening criteria. As a result of this assessment, the reasons for non-adherence to Chlamydia screening criteria at the provider level will be identified and possible opportunities for improvement can be proposed

Provider Assessment Step 1: KII’s conducted with 8 providers –Current practices –Why screen? –Awareness of regional screening criteria

Provider Assessment Preliminary findings from the key informant interviews indicate reasons for lack of adherence are: –unawareness of the screening criteria, –lack of buy-in, –poor documentation of risk factors?, –under-/ over-estimation of risk.

“I don’t know what the CDC ones are, but here we basically screen everybody. If somebody comes into the office, and cannot show me documented evidence of a negative CT screen in the past year, I will do a screening.” “For anyone coming in I offer it – I always ask if she’s interested in it – my clinical practice is to offer it to everyone regardless of age – and leave it up to them to decide.” Provider Assessment

Step 2: Survey –Web-based data collection –Invitation via FP partners and IPP AB representatives –Provider population –MA/and rest of states split up Provider Assessment

N=302 75%= Target audience - MD/NP,RN, FP/HIV Counselor 37% are MD/NPs 13% are RN/LPN 25% FP/HIV Counselors Provider Assessment

Type of Agency Family Planning Clinic 62% CHC15% STD Clinic10% Other12% (N=302 Responses)

State Participation

Provider Assessment Findings EMR Using/ Transitioning to EMR 30% Paper only70%

IPP or Not to IPP 34% IPP 26% Not IPP 38% Don’t Know Among MD/NP’s 40% didn’t know IPP project or not 33% of MD/NP and RN’s didn’t know

Provider Assessment - Results Chlamydia Screening - Practices Providers estimated that their clinic’s average Chlamydia positivity rate is 10.3%

Screening practices IPP

“I offer Chlamydia testing to everyone and leave it up to them to decide” True: 66% Overall 62% of IPP 79% of FP Clinic Representatives 73.4% of MD/NP Only’s “I screen everyone I can” True: 46% Overall 34% IPP 52% FP Clinic Representatives 52% MD/NP Only’s

Provider Assessment - Results Chlamydia Screening – CDC Recommendations Screen all sexually active females under 26 at least once a year and women over 26 who are at increased risk. No screening criteria for males Screen all sexually active males and females under 26 at least once a year and women and men over 26 who are at increased risk Screen all women of childbearing age and pregnant women

Provider Assessment - Results Provider’s Opinions on EPT 25% of responders currently practice EPT in their clinics

Source of Info re: CT screening General 10% hears from IPP rep 24% of those who know they are in IPP project hear from IPP rep – Clinic Specific 8% hears from IPP rep 21% of those who know they are in IPP say they hear from IPP rep -

Provider Assessment - Results Chlamydia Screening – Rescreening Practices Provider’s estimate… 50.3% of women treated for Chlamydia come back to be re- screened 10% of those re-screened are positive (although 40% estimate less than 3%)

Re-screening Practices “Ask patients to contact us and make appointment when re-screen time has arrived” –50% general –58% of FP representatives –67% of IPP “Yes” “Ask Pts. To come back for ‘Test of Cure’” –30% general –40% of MD/NP’s and RN’s –24% IPP “Yes”

Pregnancy Test Only TRUEFALSE Our policy is to screen all urine samples received for a pregnancy test (at least in women under 25) unless the patient declines. 39.5%60.5% Our policy is to offer screening of all urine samples received for pregnancy tests (at least in women under 25) and if they think they need it then we screen. 45.8%54.2% Our policy is not to differentiate between those under 25 and those over 25 in STD screening for Pregnancy Test “Only” Patients. 42.4%57.6%

Pregnancy Test Only TRUEFALSE Our policy is to only do Chlamydia testing during scheduled visits and annual exams. 24.3%75.7% I do not have time to do STD screening on walk-in Pregnancy Test “Only” visits. 9.3%90.7%

Next Steps: Further analysis of survey findings Send results to you by state, by? Focus groups (TBD) Performance Improvement Plan Questions? Ideas?